Cargando…
Schiff Bases of Pioglitazone Provide Better Antidiabetic and Potent Antioxidant Effect in a Streptozotocin–Nicotinamide-Induced Diabetic Rodent Model
[Image: see text] Pioglitazone is a Food and Drug Administration-approved thiazolidinedione (TZD) derivative and peroxisome proliferator-activated receptor gamma (PPARγ) agonist and used for the treatment of diabetes mellitus (DM). However, this drug is still associated with many adverse effects. In...
Autores principales: | Afzal, Hafiza Rabia, Khan, Najm ul Hassan, Sultana, Kishwar, Mobashar, Aisha, Lareb, Aqsa, Khan, Ayesha, Gull, Abrashim, Afzaal, Hasan, Khan, Muhammad Tariq, Rizwan, Muhammad, Imran, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893790/ https://www.ncbi.nlm.nih.gov/pubmed/33623853 http://dx.doi.org/10.1021/acsomega.0c06064 |
Ejemplares similares
-
Schiff-Based Metal Complexes of Lamotrigine: Design,
Synthesis, Characterization, and Biological Evaluation
por: Najm, Saima, et al.
Publicado: (2021) -
Comparative Antihyperglycemic and Antihyperlipidemic Effects of Lawsone Methyl Ether and Lawsone in Nicotinamide-Streptozotocin-Induced Diabetic Rats
por: Khan, Muhammad, et al.
Publicado: (2023) -
Antidiabetic Activity of Polyherbal Formulation in Streptozotocin – Nicotinamide Induced Diabetic Wistar Rats
por: Petchi, Rajendran Ramesh, et al.
Publicado: (2014) -
Antidiabetic Activity of Benzopyrone Analogues in Nicotinamide-Streptozotocin Induced Type 2 Diabetes in Rats
por: Nayak, Yogendra, et al.
Publicado: (2014) -
Antidiabetic activity enhancement in streptozotocin + nicotinamide–induced diabetic rats through combinational polymeric nanoformulation
por: Rani, Ruma, et al.
Publicado: (2019)